Digitisation | November 14, 2023
Bayer and Recursion focus research collaboration on Oncology
Digitally enabled drug discovery for oncology with potential to accelerate the delivery of new cancer therapies to patients
Digitally enabled drug discovery for oncology with potential to accelerate the delivery of new cancer therapies to patients
Our collaboration with MediSage to present 'Current Approaches to Uro-Oncology' embodies a crucial stride towards comprehensive cancer care
Boostimmune will have access to WuXi XDC's fully integrated one-stop bioconjugate platform
Despite the price increases for raw materials and logistics, EBITDA pre rose organically by 3.2% to € 1,782 million
This new €59 million, 70,000 square foot facility, officially opened today, brings 50 new jobs to the area
PRP is a mixture of two proenzymes, trypsinogen and chymotrypsinogen from bovine pancreas administered by intravenous injection
Globally, cervical cancer is the fourth most common cancer among women, with approximately 30,447 new cases diagnosed in Europe in 2020
At an affordable price, a researcher can process fresh samples of 10,000 cells immediately with a stable stopping point within two hours, simplifying sample management at the laboratory and limiting transcriptional changes
Shoreline has developed a proprietary methodology to create differentiated iNK cells for large-scale, "off-the-shelf" production
BVX-0922 to target colorectal cancer under investigator-sponsored IND
Subscribe To Our Newsletter & Stay Updated
